1 배승오, "한국형 정신분열병 약물치료 알고리듬의 임상 적용 가능성 (I): 치료효과 측면에서의 분석" 대한정신약물학회 17 (17): 24-34, 2006
2 민경준, "한국형 양극성 장애 약물치료 알고리듬 2006(Ⅲ):우울 삽화" 대한정신약물학회 17 (17): 436-448, 2006
3 윤보현, "한국형 양극성 장애 약물치료 알고리듬 2006(V):유지치료" 대한정신약물학회 17 (17): 528-537, 2006
4 전덕인, "한국형 양극성 장애 약물치료 알고리듬 2006(IV):급속순환형" 대한정신약물학회 17 (17): 449-455, 2006
5 신영철, "한국형 양극성 장애 약물치료 알고리듬 2006(II): 조증 삽화" 대한정신약물학회 17 (17): 362-373, 2006
6 전덕인, "한국형 양극성 장애 약물치료 알고리듬 2006(I)" 대한정신약물학회 17 (17): 349-361, 2006
7 박원명, "양극성 장애의 한국형 약물치료 알고리듬" 대한정신약물학회 13 (13): 205-221, 2002
8 Schneck CD, "Treatment of rapid-cycling bipolar disorder" 67 (67): 22-27, 2006
9 Antai-Otong D, "Treatment considerations for patients experiencing rapid-cycling bipolar disorder" 42 : 55-58, 2006
10 Suppes T, "The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder" 66 : 870-886, 2005
1 배승오, "한국형 정신분열병 약물치료 알고리듬의 임상 적용 가능성 (I): 치료효과 측면에서의 분석" 대한정신약물학회 17 (17): 24-34, 2006
2 민경준, "한국형 양극성 장애 약물치료 알고리듬 2006(Ⅲ):우울 삽화" 대한정신약물학회 17 (17): 436-448, 2006
3 윤보현, "한국형 양극성 장애 약물치료 알고리듬 2006(V):유지치료" 대한정신약물학회 17 (17): 528-537, 2006
4 전덕인, "한국형 양극성 장애 약물치료 알고리듬 2006(IV):급속순환형" 대한정신약물학회 17 (17): 449-455, 2006
5 신영철, "한국형 양극성 장애 약물치료 알고리듬 2006(II): 조증 삽화" 대한정신약물학회 17 (17): 362-373, 2006
6 전덕인, "한국형 양극성 장애 약물치료 알고리듬 2006(I)" 대한정신약물학회 17 (17): 349-361, 2006
7 박원명, "양극성 장애의 한국형 약물치료 알고리듬" 대한정신약물학회 13 (13): 205-221, 2002
8 Schneck CD, "Treatment of rapid-cycling bipolar disorder" 67 (67): 22-27, 2006
9 Antai-Otong D, "Treatment considerations for patients experiencing rapid-cycling bipolar disorder" 42 : 55-58, 2006
10 Suppes T, "The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder" 66 : 870-886, 2005
11 이민수, "The Korean Medication Algorithm for Major Depressive Disorder (KMA-MDD): Report of the Korean Society of Depressive and Bipolar Disorders" 10 : 186-194, 200601
12 Keck PE, "The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2004" 1-116, 2004
13 Jon DI, "Revised Korean medication algorithm for bipolar disorder" 10 : 846-855, 2009
14 Woo YS, "Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: A multicenter, prospective, naturalistic, open-label trial" PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB 33 (33): 1147-1152, 200906
15 Ananth J, "Rapid cycling patients: conceptual and etiological factors" 27 : 193-198, 1993
16 Wehr TA, "Rapid cycling in manic-depressives induced by tricyclic antidepressants" 36 : 555-559, 1979
17 Wehr TA, "Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients" 145 : 179-184, 1988
18 Sanger TM, "Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling" 73 : 155-161, 2003
19 Bauer MS, "Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV" 151 : 506-515, 1994
20 Mattsson A, "MAOI-induced rapid cycling bipolar affective disorder in an adolescent" 138 : 677-679, 1981
21 Woo YS, "Lamotrigine added to valproate successfully treated a case of ultra-rapid cycling bipolar disorder" 61 : 130-131, 2007
22 Leibenluft E, "Issues in the treatment of women with bipolar illness" 58 (58): 5-11, 1997
23 Berman E, "Intractable manic-depressive psychosis with rapid cycling in an 18-year-old woman successfully treated with electroconvulsive therapy" 175 : 236-, 1987
24 Goodwin GM, "Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology" 17 : 149-173, 2003
25 Valenti M, "Electroconvulsive therapy in the treatment of mixed states in bipolar disorder" 23 : 53-56, 2008
26 Americal Psychiatric Association, "Diagnostic and statistical manual of mental disorders" American Psychiatric Association 2000
27 Denicoff KD, "Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder" 58 : 470-478, 1997
28 Suppes T, "Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases" 36 : 338-340, 1994
29 Calabrese J, "Clozapine prophylaxis in rapid cycling bipolar disorder" 11 : 396-397, 1991
30 Calabrese JR, "Clinical highlights in bipolar depression: focus on atypical antipsychotics" 66 (66): 26-33, 2005
31 Dunner DL, "Clinical factors in lithium carbonate prophylaxis failure" 30 : 229-233, 1974
32 Yatham LN, "Canadian Network for Mood and Anxiety Treatments(CANMAT)guidelines for the management of patients with bipolar disorder: consensus and controversies" 7 (7): 5-69, 2005
33 Calabrese JR, "Bipolar rapid cycling: focus on depression as its hallmark" 62 (62): 34-41, 2001
34 Dell’Osso B, "Augmentative transcranial magnetic stimulation (TMS) combined with brain navigation in drug-resistant rapid cycling bipolar depression: A case report of acute and maintenance efficacy" 10 : 673-676, 2009
35 Dell’Osso B, "Augmentative repetitive navigated transcranial magnetic stimulation(rTMS) in drug-resistant bipolar depression" 11 : 76-81, 2009
36 Jon DI, "Algorithm-driven treatment for bipolar disorder in Korea: Clinical feasibility, efficacy, and safety" 13 : 122-129, 2009
37 Yatham LN, "Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics" 5 (5): 7-19, 2003
38 Delbello MP, "A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania" 41 : 1216-1223, 2002
39 George M, "A controlled trial of daily left prefrontal cortex TMS for treating depression" 48 : 962-970, 2000